{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:06Z","timestamp":1790646966021,"version":"4.1.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05161-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T03:35:36Z","timestamp":1783308936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of microRNAs in cisplatin response of cancer stem cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Meysam","family":"Moghbeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Payami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"19","key":"5161_CR1","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells\u2014perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66(19):9339\u201344.","journal-title":"Cancer Res"},{"issue":"10","key":"5161_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc3597","volume":"13","author":"B Beck","year":"2013","unstructured":"Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer. 2013;13(10):727\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"5161_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00535-012-0712-y","volume":"48","author":"G Xu","year":"2013","unstructured":"Xu G, Shen J, Ou Yang X, Sasahara M, Su X. Cancer stem cells: the \u2018heartbeat\u2019of gastric cancer. J Gastroenterol. 2013;48(7):781\u201397.","journal-title":"J Gastroenterol"},{"issue":"8","key":"5161_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat reviews Clin Oncol. 2015;12(8):445\u201364.","journal-title":"Nat reviews Clin Oncol"},{"issue":"5","key":"5161_CR5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3892\/or.2013.2294","volume":"29","author":"G Pirozzi","year":"2013","unstructured":"Pirozzi G, Tirino V, Camerlingo R, La Rocca A, Martucci N, Scognamiglio G, et al. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep. 2013;29(5):1763\u20138.","journal-title":"Oncol Rep"},{"issue":"24","key":"5161_CR6","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1158\/0008-5472.CAN-12-4704","volume":"73","author":"E Charafe-Jauffret","year":"2013","unstructured":"Charafe-Jauffret E, Ginestier C, Bertucci F, Cabaud O, Wicinski J, Finetti P, et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res. 2013;73(24):7290\u2013300.","journal-title":"Cancer Res"},{"issue":"3","key":"5161_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ccr.2013.02.021","volume":"23","author":"MS Schieber","year":"2013","unstructured":"Schieber MS, Chandel NS. ROS links glucose metabolism to breast cancer stem cell and EMT phenotype. Cancer Cell. 2013;23(3):265\u20137.","journal-title":"Cancer Cell"},{"issue":"3","key":"5161_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s13277-013-1321-y","volume":"35","author":"J Organista-Nava","year":"2014","unstructured":"Organista-Nava J, G\u00f3mez-G\u00f3mez Y, Gariglio P. Embryonic stem cell-specific signature in cervical cancer. Tumor Biology. 2014;35(3):1727\u201338.","journal-title":"Tumor Biology"},{"issue":"11","key":"5161_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/14737159.2018.1538794","volume":"18","author":"K Panoutsopoulou","year":"2018","unstructured":"Panoutsopoulou K, Avgeris M, Scorilas A. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers. Expert Rev Mol Diagn. 2018;18(11):963\u201379.","journal-title":"Expert Rev Mol Diagn"},{"issue":"5543","key":"5161_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853\u20138.","journal-title":"Science"},{"issue":"1","key":"5161_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12672-024-01270-z","volume":"15","author":"I Akhlaghipour","year":"2024","unstructured":"Akhlaghipour I, Moghbeli M. MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients. Discov Oncol. 2024;15(1):385.","journal-title":"Discov Oncol"},{"issue":"2","key":"5161_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ceb.2004.02.006","volume":"16","author":"K Nakahara","year":"2004","unstructured":"Nakahara K, Carthew RW. Expanding roles for miRNAs and siRNAs in cell regulation. Curr Opin Cell Biol. 2004;16(2):127\u201333.","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"5161_CR13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1742-4658.2011.08087.x","volume":"278","author":"A Ichimura","year":"2011","unstructured":"Ichimura A, Ruike Y, Terasawa K, Tsujimoto G. miRNAs and regulation of cell signaling. FEBS J. 2011;278(10):1610\u20138.","journal-title":"FEBS J"},{"issue":"Pt 2","key":"5161_CR14","doi-asserted-by":"publisher","first-page":"142912","DOI":"10.1016\/j.ijbiomac.2025.142912","volume":"309","author":"M Moghbeli","year":"2025","unstructured":"Moghbeli M. MicroRNAs as the critical regulators of bone metastasis during prostate tumor progression. Int J Biol Macromol. 2025;309(Pt 2):142912.","journal-title":"Int J Biol Macromol"},{"key":"5161_CR15","doi-asserted-by":"publisher","first-page":"155547","DOI":"10.1016\/j.prp.2024.155547","volume":"262","author":"F Tolue Ghasaban","year":"2024","unstructured":"Tolue Ghasaban F, Taghehchian N, Zangouei AS, Keivany MR, Moghbeli M. MicroRNA-135b mainly functions as an oncogene during tumor progression. Pathol Res Pract. 2024;262:155547.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"5161_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"5161_CR17","first-page":"101728","volume":"38","author":"Y Rajabloo","year":"2024","unstructured":"Rajabloo Y, Latifi H, Akhlaghipour I, Taghehchian N, Moghbeli M. MicroRNA-409: Molecular functions and clinical applications in cancer. Biochem Biophys Rep. 2024;38:101728.","journal-title":"Biochem Biophys Rep"},{"issue":"3","key":"5161_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/carcin\/bgs371","volume":"34","author":"I-S Hsieh","year":"2013","unstructured":"Hsieh I-S, Chang K-C, Tsai Y-T, Ke J-Y, Lu P-J, Lee K-H, et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt\/beta-catenin signaling pathway. Carcinogenesis. 2013;34(3):530\u20138.","journal-title":"Carcinogenesis"},{"issue":"3","key":"5161_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szak\u00e1cs","year":"2006","unstructured":"Szak\u00e1cs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219\u201334.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"5161_CR20","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1158\/1535-7163.MCT-15-0171","volume":"14","author":"JL Roh","year":"2015","unstructured":"Roh JL, Kim EH, Park JY, Kim JW. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin. Mol Cancer Ther. 2015;14(8):1907\u201315.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"5161_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3892\/br.2016.594","volume":"4","author":"K Tao","year":"2016","unstructured":"Tao K, Yin Y, Shen Q, Chen Y, Li R, Chang W, et al. Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells. Biomed Rep. 2016;4(3):365\u20138.","journal-title":"Biomed Rep"},{"issue":"9","key":"5161_CR22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson ER, Lippard SJ. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev. 1999;99(9):2467\u201398.","journal-title":"Chem Rev"},{"issue":"6","key":"5161_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000334093","volume":"57","author":"AI Shamseddine","year":"2011","unstructured":"Shamseddine AI, Farhat FS. Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy. 2011;57(6):468\u201387.","journal-title":"Chemotherapy"},{"issue":"5","key":"5161_CR24","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1021\/cr068207j","volume":"107","author":"Y Jung","year":"2007","unstructured":"Jung Y, Lippard SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev. 2007;107(5):1387\u2013407.","journal-title":"Chem Rev"},{"issue":"15","key":"5161_CR25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"issue":"2","key":"5161_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1593\/neo.131744","volume":"16","author":"C Noer","year":"2014","unstructured":"Noer C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, et al. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia. 2014;16(2):137\u2013W8.","journal-title":"Neoplasia"},{"key":"5161_CR27","unstructured":"Boutou E, Vlachodimitropoulos D. mlouka@di.uoa.gr M, Bakou V, Georgoulis A. DNA Damage Response\/Repair in Cancer Stem Cells \u2014 Potential vs. Controversies. In: Chen CC, editor. Advances in DNA Repair. London: IntechOpen; 2015."},{"key":"5161_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2016.09.003","volume":"47","author":"M Majidinia","year":"2016","unstructured":"Majidinia M, Yousefi B. DNA damage response regulation by microRNAs as a therapeutic target in cancer. DNA Repair. 2016;47:1\u201311.","journal-title":"DNA Repair"},{"issue":"3","key":"5161_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/ijms17030424","volume":"17","author":"I Riquelme","year":"2016","unstructured":"Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Emerging role of miRNAs in the drug resistance of gastric cancer. Int J Mol Sci. 2016;17(3):424.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5161_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s13105-024-01022-1","volume":"80","author":"A Nasimi Shad","year":"2024","unstructured":"Nasimi Shad A, Akhlaghipour I, Alshakarchi HI, Saburi E, Moghbeli M. Role of microRNA-363 during tumor progression and invasion. J Physiol Biochem. 2024;80(3):481\u201399.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"5161_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12935-023-02925-7","volume":"23","author":"F Tolue Ghasaban","year":"2023","unstructured":"Tolue Ghasaban F, Maharati A, Akhlaghipour I, Moghbeli M. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells. Cancer Cell Int. 2023;23(1):80.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5161_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12935-023-03010-9","volume":"23","author":"F Tolue Ghasaban","year":"2023","unstructured":"Tolue Ghasaban F, Maharati A, Zangouei AS, Zangooie A, Moghbeli M. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. Cancer Cell Int. 2023;23(1):170.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5161_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbrc.2014.03.135","volume":"447","author":"J Tang","year":"2014","unstructured":"Tang J, Tao ZH, Wen D, Wan JL, Liu DL, Zhang S, et al. MiR-612 suppresses the stemness of liver cancer via Wnt\/\u03b2-catenin signaling. Biochem Biophys Res Commun. 2014;447(1):210\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"5161_CR34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.biopha.2018.10.080","volume":"109","author":"L Shi","year":"2019","unstructured":"Shi L, Xi J, Xu X, Peng B, Zhang B. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating \u03b2-catenin signaling in cisplatin-resistant colorectal cancer cells. Biomed Pharmacother. 2019;109:902\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"5161_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ncb1001","volume":"5","author":"NM Wikonkal","year":"2003","unstructured":"Wikonkal NM, Remenyik E, Knezevic D, Zhang W, Liu M, Zhao H, et al. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol. 2003;5(7):655\u201360.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"5161_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(03)00344-7","volume":"12","author":"FA Dick","year":"2003","unstructured":"Dick FA, Dyson N. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell. 2003;12(3):639\u201349.","journal-title":"Mol Cell"},{"issue":"1","key":"5161_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-021-01896-9","volume":"40","author":"Y Xia","year":"2021","unstructured":"Xia Y, Lv J, Jiang T, Li B, Li Y, He Z, et al. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p\/HMGA2 positive feedback loop and HNRNPK-mediated \u03b2-catenin stabilization. J Experimental Clin Cancer Res. 2021;40(1):103.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"3","key":"5161_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2018.1529101","volume":"20","author":"S Cheng","year":"2019","unstructured":"Cheng S, Huang Y, Lou C, He Y, Zhang Y, Zhang Q. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin \u03b23\/Wnt signaling under miR-137 regulation. Cancer Biol Ther. 2019;20(3):328\u201337.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"5161_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15(3):504\u201314.","journal-title":"Cell Death Differ"},{"issue":"49","key":"5161_CR40","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41388-018-0411-0","volume":"37","author":"C-H Lu","year":"2018","unstructured":"Lu C-H, Yeh D-W, Lai C-Y, Liu Y-L, Huang L-R, Lee AY-L, et al. USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2\/TRAF3 complex formation. Oncogene. 2018;37(49):6327\u201340.","journal-title":"Oncogene"},{"issue":"24","key":"5161_CR41","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"S-H Chiou","year":"2010","unstructured":"Chiou S-H, Wang M-L, Chou Y-T, Chen C-J, Hong C-F, Hsieh W-J, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell\u2013like properties and epithelial\u2013mesenchymal transdifferentiation. Cancer Res. 2010;70(24):10433\u201344.","journal-title":"Cancer Res"},{"issue":"2","key":"5161_CR42","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3892\/etm.2020.8847","volume":"20","author":"S Wu","year":"2020","unstructured":"Wu S, Wang H, Pan Y, Yang X, Wu D. miR-140-3p enhances cisplatin sensitivity and attenuates stem cell-like properties through repressing Wnt\/\u03b2-catenin signaling in lung adenocarcinoma cells. Experimental Therapeutic Med. 2020;20(2):1664\u201374.","journal-title":"Experimental Therapeutic Med"},{"issue":"47","key":"5161_CR43","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"L Austin Doyle","year":"2003","unstructured":"Austin Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22(47):7340\u201358.","journal-title":"Oncogene"},{"issue":"23","key":"5161_CR44","first-page":"5938","volume":"59","author":"M Brangi","year":"1999","unstructured":"Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, et al. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res. 1999;59(23):5938\u201346.","journal-title":"Cancer Res"},{"issue":"1","key":"5161_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/scd.2008.0055","volume":"18","author":"J Douville","year":"2009","unstructured":"Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 2009;18(1):17\u201325.","journal-title":"Stem Cells Dev"},{"issue":"6","key":"5161_CR46","doi-asserted-by":"publisher","first-page":"101042831771515","DOI":"10.1177\/1010428317715155","volume":"39","author":"B Chen","year":"2017","unstructured":"Chen B, Zhang D, Kuai J, Cheng M, Fang X, Li G. Upregulation of miR-199a\/b contributes to cisplatin resistance via Wnt\/\u03b2-catenin-ABCG2 signaling pathway in ALDHA1\u2009+\u2009colorectal cancer stem cells. Tumor Biology. 2017;39(6):1010428317715155.","journal-title":"Tumor Biology"},{"issue":"1","key":"5161_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12885-017-3192-x","volume":"17","author":"W Wang","year":"2017","unstructured":"Wang W, Li Y, Liu N, Gao Y, Li L. MiR-23b controls ALDH1A1 expression in cervical cancer stem cells. BMC Cancer. 2017;17(1):292.","journal-title":"BMC Cancer"},{"issue":"17","key":"5161_CR48","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","volume":"67","author":"J Konishi","year":"2007","unstructured":"Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, et al. \u03b3-Secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res. 2007;67(17):8051\u20137.","journal-title":"Cancer Res"},{"issue":"4","key":"5161_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12029-015-9753-9","volume":"46","author":"M Moghbeli","year":"2015","unstructured":"Moghbeli M, Forghanifard MM, Sadrizadeh A, Mozaffari HM, Golmakani E, Abbaszadegan MR. Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma. J Gastrointest cancer. 2015;46(4):365\u20139.","journal-title":"J Gastrointest cancer"},{"issue":"1","key":"5161_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13287-018-1072-1","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Meng Q, Qiao W, Ma R, Ju W, Hu J, et al. miR-181b\/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC. Stem Cell Res Ther. 2018;9(1):327.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"5161_CR51","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbamcr.2011.03.004","volume":"1813","author":"B S\u00e1nchez-Solana","year":"2011","unstructured":"S\u00e1nchez-Solana B, Nueda ML, Ruvira MD, Ruiz-Hidalgo MJ, Monsalve EM, Rivero S, et al. The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other\u2019s activities. Biochim et Biophys Acta (BBA)-Molecular Cell Res. 2011;1813(6):1153\u201364.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Cell Res"},{"issue":"4","key":"5161_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cellsig.2016.01.003","volume":"28","author":"G\u00c1 Traustad\u00f3ttir","year":"2016","unstructured":"Traustad\u00f3ttir G\u00c1, Jensen CH, Thomassen M, Beck HC, Mortensen SB, Laborda J, et al. Evidence of non-canonical NOTCH signaling: Delta-like 1 homolog (DLK1) directly interacts with the NOTCH1 receptor in mammals. Cell Signal. 2016;28(4):246\u201354.","journal-title":"Cell Signal"},{"issue":"11","key":"5161_CR53","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.bbamcr.2014.07.015","volume":"1843","author":"M-L Nueda","year":"2014","unstructured":"Nueda M-L, Naranjo A-I, Baladr\u00f3n V, Laborda J. The proteins DLK1 and DLK2 modulate NOTCH1-dependent proliferation and oncogenic potential of human SK-MEL-2 melanoma cells. Biochim et Biophys Acta (BBA)-Molecular Cell Res. 2014;1843(11):2674\u201384.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Cell Res"},{"issue":"2","key":"5161_CR54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/cvr\/cvr296","volume":"93","author":"P Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez P, Higueras MA, Gonzalez-Rajal A, Alfranca A, Fierro-Fernandez M, Garc\u00eda-Fern\u00e1ndez RA, et al. The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. Cardiovascular Res. 2012;93(2):232\u201341.","journal-title":"Cardiovascular Res"},{"issue":"2","key":"5161_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbrc.2017.06.041","volume":"490","author":"Z Ma","year":"2017","unstructured":"Ma Z, Cai H, Zhang Y, Chang L, Cui Y. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. Biochem Biophys Res Commun. 2017;490(2):309\u201316.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"5161_CR56","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921\u20135.","journal-title":"Curr Biol"},{"issue":"10","key":"5161_CR57","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J, et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 2023;12(10):11149\u201365.","journal-title":"Cancer Med"},{"key":"5161_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41021-020-00157-z","volume":"42","author":"MR Abbaszadegan","year":"2020","unstructured":"Abbaszadegan MR, Mojarrad M, Moghbeli M. Role of extra cellular proteins in gastric cancer progression and metastasis: an update. Genes environment: official J Japanese Environ Mutagen Soc. 2020;42:18.","journal-title":"Genes environment: official J Japanese Environ Mutagen Soc"},{"key":"5161_CR59","doi-asserted-by":"publisher","first-page":"668349","DOI":"10.3389\/fonc.2021.668349","volume":"11","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin G. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion. Front Oncol. 2021;11:668349.","journal-title":"Front Oncol"},{"key":"5161_CR60","doi-asserted-by":"crossref","unstructured":"Joshi RS, Kanugula SS, Sudhir S, Pereira MP, Jain S, Aghi MK. The Role of Cancer-Associated Fibroblasts in Tumor Progression. Cancers (Basel). 2021;13(6).","DOI":"10.3390\/cancers13061399"},{"issue":"1","key":"5161_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6(1):218.","journal-title":"Signal Transduct Target Ther"},{"key":"5161_CR62","doi-asserted-by":"publisher","first-page":"1343523","DOI":"10.3389\/fmolb.2024.1343523","volume":"11","author":"O Piwocka","year":"2024","unstructured":"Piwocka O, Piotrowski I, Suchorska WM, Kulcenty K. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy. Front Mol Biosci. 2024;11:1343523.","journal-title":"Front Mol Biosci"},{"key":"5161_CR63","doi-asserted-by":"publisher","first-page":"215796","DOI":"10.1016\/j.canlet.2022.215796","volume":"543","author":"Y Huang","year":"2022","unstructured":"Huang Y, Kanada M, Ye J, Deng Y, He Q, Lei Z, et al. Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication. Cancer Lett. 2022;543:215796.","journal-title":"Cancer Lett"},{"issue":"1","key":"5161_CR64","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1186\/s12967-025-06794-8","volume":"23","author":"L Yang","year":"2025","unstructured":"Yang L, Zhao S, Liu X, Zhang Y, Zhao S, Fang X, et al. Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p\/NOTCH1 signaling. J Transl Med. 2025;23(1):814.","journal-title":"J Transl Med"},{"key":"5161_CR65","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ijbiomac.2022.11.236","volume":"226","author":"I Akhlaghipour","year":"2023","unstructured":"Akhlaghipour I, Taghehchian N, Zangouei AS, Maharati A, Mahmoudian RA, Saburi E, et al. MicroRNA-377: A therapeutic and diagnostic tumor marker. Int J Biol Macromol. 2023;226:1226\u201335.","journal-title":"Int J Biol Macromol"},{"key":"5161_CR66","doi-asserted-by":"publisher","first-page":"154538","DOI":"10.1016\/j.prp.2023.154538","volume":"247","author":"A Nasimi Shad","year":"2023","unstructured":"Nasimi Shad A, Fanoodi A, Maharati A, Akhlaghipour I, Moghbeli M. Molecular mechanisms of microRNA-301a during tumor progression and metastasis. Pathol Res Pract. 2023;247:154538.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"5161_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, Ten Dijke P. Targeting TGF-\u03b2 Signaling in Cancer. Trends Cancer. 2017;3(1):56\u201371.","journal-title":"Trends Cancer"},{"issue":"1","key":"5161_CR68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","volume":"40","author":"C Song","year":"2021","unstructured":"Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis. J Exp Clin Cancer Res. 2021;40(1):62.","journal-title":"J Exp Clin Cancer Res"},{"key":"5161_CR69","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.2147\/IJGM.S476647","volume":"17","author":"X Nie","year":"2024","unstructured":"Nie X, Liu J, Wang D, Li C, Teng Y, Li Z, et al. MiR-21-5p Modulates Cisplatin-Resistance of CD44\u2009+\u2009Gastric Cancer Stem Cells Through Regulating the TGF-\u03b22\/SMAD Signaling Pathway. Int J Gen Med. 2024;17:4579\u201393.","journal-title":"Int J Gen Med"},{"issue":"1","key":"5161_CR70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2407-6-91","volume":"6","author":"H Wang","year":"2006","unstructured":"Wang H, Zhao L-N, Li K-Z, Ling R, Li X-J, Wang L. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer. 2006;6(1):91.","journal-title":"BMC Cancer"},{"issue":"5","key":"5161_CR71","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.21037\/tcr.2020.04.13","volume":"9","author":"Y Ma","year":"2020","unstructured":"Ma Y, Xue H, Wang W, Yuan Y, Liang F. The miR-567\/RPL15\/TGF-\u03b2\/Smad axis inhibits the stem-like properties and chemo-resistance of gastric cancer cells. Transl Cancer Res. 2020;9(5):3539\u201349.","journal-title":"Transl Cancer Res"},{"key":"5161_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biopha.2018.01.054","volume":"99","author":"S-l Tang","year":"2018","unstructured":"Tang S-l, Gao Y-l, Wen-Zhong H. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K\/Akt signaling pathway. Biomed Pharmacother. 2018;99:59\u201364.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5161_CR73","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/path.5144","volume":"246","author":"Y Li","year":"2018","unstructured":"Li Y, Deng L, Zhao X, Li B, Ren D, Yu L, et al. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non\u2010small\u2010cell lung cancer cells by activating the NF\u2010\u03baB pathway. J Pathol. 2018;246(3):366\u201378.","journal-title":"J Pathol"},{"issue":"3","key":"5161_CR74","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3892\/mmr.2017.6125","volume":"15","author":"CE Hu","year":"2017","unstructured":"Hu CE, Gan J. TRIM37 promotes epithelial\u2013mesenchymal transition in colorectal cancer. Mol Med Rep. 2017;15(3):1057\u201362.","journal-title":"Mol Med Rep"},{"issue":"6","key":"5161_CR75","first-page":"6365","volume":"14","author":"Y Tao","year":"2017","unstructured":"Tao Y, Xin M, Cheng H, Huang Z, Hu T, Zhang T, et al. TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma. Oncol Lett. 2017;14(6):6365\u201372.","journal-title":"Oncol Lett"},{"issue":"11","key":"5161_CR76","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41419-019-2070-7","volume":"10","author":"C Xiao","year":"2019","unstructured":"Xiao C, Wu G, Zhou Z, Zhang X, Wang Y, Song G, et al. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial\u2013mesenchymal transition and promotes metastasis of colorectal cancer. Cell Death Dis. 2019;10(11):833.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5161_CR77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10120-020-01096-y","volume":"24","author":"T Fu","year":"2021","unstructured":"Fu T, Ji K, Jin L, Zhang J, Wu X, Ji X, et al. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-\u03baB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer. Gastric Cancer. 2021;24(1):45\u201359.","journal-title":"Gastric Cancer"},{"issue":"12","key":"5161_CR78","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s11010-022-04480-7","volume":"477","author":"F Chi","year":"2022","unstructured":"Chi F, Jin X, Chen L, He G, Han S. TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-\u03baB pathway. Mol Cell Biochem. 2022;477(12):2801\u201316.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"5161_CR79","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.18632\/oncotarget.1651","volume":"4","author":"JH Chung","year":"2013","unstructured":"Chung JH, Bunz F. A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis. Oncotarget. 2013;4(12):2208.","journal-title":"Oncotarget"},{"issue":"17","key":"5161_CR80","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1200\/JCO.2007.15.2264","volume":"26","author":"X Fan","year":"2008","unstructured":"Fan X, Eberhart CG. Medulloblastoma stem cells. J Clin Oncol. 2008;26(17):2821\u20137.","journal-title":"J Clin Oncol"},{"issue":"12","key":"5161_CR81","doi-asserted-by":"publisher","first-page":"23111","DOI":"10.1002\/jcp.28874","volume":"234","author":"Z Yuan","year":"2019","unstructured":"Yuan Z, Xiu C, Liu D, Zhou G, Yang H, Pei R, et al. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p\/PTCH1\/SHH axis. J Cell Physiol. 2019;234(12):23111\u201322.","journal-title":"J Cell Physiol"},{"key":"5161_CR82","doi-asserted-by":"crossref","unstructured":"Srivastava AK, Han C, Zhao R, Cui T, Dai Y, Mao C et al. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proceedings of the National Academy of Sciences. 2015;112(14):4411-6.","DOI":"10.1073\/pnas.1421365112"},{"issue":"4","key":"5161_CR83","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1158\/1541-7786.MCR-05-0118","volume":"4","author":"Y-w Chen","year":"2006","unstructured":"Chen Y-w, Cleaver JE, Hanaoka F, Chang C-f. Chou K-m. A novel role of DNA polymerase \u03b7 in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res. 2006;4(4):257\u201365.","journal-title":"Mol Cancer Res"},{"issue":"18","key":"5161_CR84","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1158\/0008-5472.CAN-04-1328","volume":"64","author":"E Bassett","year":"2004","unstructured":"Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, et al. The role of DNA polymerase \u03b7 in translesion synthesis past platinum\u2013DNA adducts in human fibroblasts. Cancer Res. 2004;64(18):6469\u201375.","journal-title":"Cancer Res"},{"issue":"16","key":"5161_CR85","first-page":"3968","volume":"59","author":"JT Reardon","year":"1999","unstructured":"Reardon JT, Vaisman A, Chaney SG, Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro-cyclohexylamine-platinum (IV)(JM216) platinumIntrastrand DNA diadducts. Cancer Res. 1999;59(16):3968\u201371.","journal-title":"Cancer Res"},{"issue":"15","key":"5161_CR86","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1093\/nar\/gkv691","volume":"43","author":"K Rein","year":"2015","unstructured":"Rein K, Yanez DA, Terr\u00e9 B, Palenzuela L, Aivio S, Wei K, et al. EXO1 is critical for embryogenesis and the DNA damage response in mice with a hypomorphic Nbs1 allele. Nucleic Acids Res. 2015;43(15):7371\u201387.","journal-title":"Nucleic Acids Res"},{"key":"5161_CR87","doi-asserted-by":"publisher","first-page":"e918751","DOI":"10.12659\/MSM.918751","volume":"26","author":"D He","year":"2020","unstructured":"He D, Li T, Sheng M, Yang B. Exonuclease 1 (Exo1) participates in mammalian non-homologous end joining and contributes to drug resistance in ovarian cancer. Med Sci monitor: Int Med J experimental Clin Res. 2020;26:e918751\u20131.","journal-title":"Med Sci monitor: Int Med J experimental Clin Res"},{"issue":"9","key":"5161_CR88","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1139\/cjpp-2022-0139","volume":"100","author":"P Mao","year":"2022","unstructured":"Mao P, Wu S, Fan Y. Upregulation of exonuclease 1 caused by homology-dependent repair confers cisplatin resistance to gastric cancer cells. Can J Physiol Pharmacol. 2022;100(9):903\u201314.","journal-title":"Can J Physiol Pharmacol"},{"key":"5161_CR89","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2019.00438","volume":"10","author":"B Pilzecker","year":"2019","unstructured":"Pilzecker B, Jacobs H. Mutating for good: DNA damage responses during somatic hypermutation. Front Immunol. 2019;10:438.","journal-title":"Front Immunol"},{"issue":"10","key":"5161_CR90","doi-asserted-by":"publisher","first-page":"a010363","DOI":"10.1101\/cshperspect.a010363","volume":"5","author":"MF Goodman","year":"2013","unstructured":"Goodman MF, Woodgate R. Translesion DNA polymerases. Cold Spring Harb Perspect Biol. 2013;5(10):a010363.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"5161_CR91","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41416-024-02840-2","volume":"131","author":"T Mandal","year":"2024","unstructured":"Mandal T, Shukla D, Khan MMA, Ganesan SK, Srivastava AK. The EXO1\/Pol\u03b7\/Pol\u03b9 axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma. Br J Cancer. 2024;131(10):1668\u201382.","journal-title":"Br J Cancer"},{"issue":"16","key":"5161_CR92","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1021\/bi000130k","volume":"39","author":"A Vaisman","year":"2000","unstructured":"Vaisman A, Masutani C, Hanaoka F, Chaney SG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase \u03b7. Biochemistry. 2000;39(16):4575\u201380.","journal-title":"Biochemistry"},{"issue":"1","key":"5161_CR93","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41419-025-07430-5","volume":"16","author":"D Shukla","year":"2025","unstructured":"Shukla D, Mishra S, Mandal T, Charan M, Verma AK, Khan MMA, et al. MicroRNA-379-5p attenuates cancer stem cells and reduces cisplatin resistance in ovarian cancer by regulating RAD18\/Pol\u03b7 axis. Cell Death Dis. 2025;16(1):140.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5161_CR94","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1242\/jcs.031682","volume":"122","author":"JK Brunelle","year":"2009","unstructured":"Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 2009;122(4):437\u201341.","journal-title":"J Cell Sci"},{"issue":"5","key":"5161_CR95","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1009616228304","volume":"5","author":"HU Simon","year":"2000","unstructured":"Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415\u20138.","journal-title":"Apoptosis"},{"issue":"34","key":"5161_CR96","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin K-M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25(34):4798\u2013811.","journal-title":"Oncogene"},{"issue":"2","key":"5161_CR97","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cas.13894","volume":"110","author":"SD Lee","year":"2019","unstructured":"Lee SD, Yu D, Lee DY, Shin H-S, Jo J-H, Lee YC. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. Cancer Sci. 2019;110(2):662\u201373.","journal-title":"Cancer Sci"},{"issue":"14","key":"5161_CR98","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.febslet.2010.05.061","volume":"584","author":"LW Thomas","year":"2010","unstructured":"Thomas LW, Lam C, Edwards SW. Mcl-1; the molecular regulation of protein function. FEBS Lett. 2010;584(14):2981\u20139.","journal-title":"FEBS Lett"},{"issue":"53","key":"5161_CR99","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","volume":"22","author":"S Cory","year":"2003","unstructured":"Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003;22(53):8590\u2013607.","journal-title":"Oncogene"},{"issue":"2","key":"5161_CR100","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3892\/mmr.2015.4727","volume":"13","author":"H He","year":"2016","unstructured":"He H, Tian W, Chen H, Deng Y. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. Mol Med Rep. 2016;13(2):1923\u20139.","journal-title":"Mol Med Rep"},{"issue":"1","key":"5161_CR101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13277-015-3591-z","volume":"37","author":"J Hu","year":"2016","unstructured":"Hu J, Xu C, Cheng B, Jin L, Li J, Gong Y, et al. Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy. Tumour Biol. 2016;37(1):331\u20139.","journal-title":"Tumour Biol"},{"issue":"13","key":"5161_CR102","doi-asserted-by":"publisher","first-page":"22003","DOI":"10.18632\/oncotarget.15781","volume":"8","author":"Q Xie","year":"2017","unstructured":"Xie Q, Wang S, Zhao Y, Zhang Z, Qin C, Yang X. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1. Oncotarget. 2017;8(13):22003\u201313.","journal-title":"Oncotarget"},{"issue":"6","key":"5161_CR103","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.4049\/jimmunol.158.6.2736","volume":"158","author":"Y Suzuki","year":"1997","unstructured":"Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol (Baltimore Md: 1950). 1997;158(6):2736\u201344.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"7183","key":"5161_CR104","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature06604","volume":"452","author":"J-R Chao","year":"2008","unstructured":"Chao J-R, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 2008;452(7183):98\u2013102.","journal-title":"Nature"},{"issue":"1","key":"5161_CR105","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2407-10-76","volume":"10","author":"A Trebinska","year":"2010","unstructured":"Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, et al. HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer. 2010;10(1):76.","journal-title":"BMC Cancer"},{"issue":"17","key":"5161_CR106","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.febslet.2014.05.042","volume":"588","author":"A Trebinska","year":"2014","unstructured":"Trebinska A, H\u00f6gstrand K, Grandien A, Grzybowska EA, Fadeel B. Exploring the anti-apoptotic role of HAX-1 versus BCL-XL in cytokine-dependent bone marrow-derived cells from mice. FEBS Lett. 2014;588(17):2921\u20137.","journal-title":"FEBS Lett"},{"issue":"5","key":"5161_CR107","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3892\/or.2015.4202","volume":"34","author":"J Yan","year":"2015","unstructured":"Yan J, Ma C, Cheng J, Li Z, Liu C. HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation. Oncol Rep. 2015;34(5):2776\u201381.","journal-title":"Oncol Rep"},{"issue":"52","key":"5161_CR108","doi-asserted-by":"publisher","first-page":"86446","DOI":"10.18632\/oncotarget.13424","volume":"7","author":"J Liu","year":"2016","unstructured":"Liu J, Tang Q, Li S, Yang X. Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells. Oncotarget. 2016;7(52):86446\u201356.","journal-title":"Oncotarget"},{"issue":"1","key":"5161_CR109","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12935-023-03086-3","volume":"23","author":"N Taghehchian","year":"2023","unstructured":"Taghehchian N, Maharati A, Akhlaghipour I, Zangouei AS, Moghbeli M. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression. Cancer Cell Int. 2023;23(1):233.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"5161_CR110","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12032-025-03004-9","volume":"42","author":"N Taghehchian","year":"2025","unstructured":"Taghehchian N, Akhlaghipour I, Zangouei AS, Palizkaran Yazdi M, Moghbeli M. Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation. Med Oncol. 2025;42(10):437.","journal-title":"Med Oncol"},{"issue":"5","key":"5161_CR111","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cellsig.2013.02.013","volume":"25","author":"K Liu","year":"2013","unstructured":"Liu K, Lin B, Zhao M, Yang X, Chen M, Gao A, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal. 2013;25(5):1264\u201371.","journal-title":"Cell Signal"},{"issue":"11","key":"5161_CR112","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.465","volume":"41","author":"AJ Bass","year":"2009","unstructured":"Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238\u201342.","journal-title":"Nat Genet"},{"issue":"4","key":"5161_CR113","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","volume":"25","author":"X Chen","year":"2019","unstructured":"Chen X, Xie R, Gu P, Huang M, Han J, Dong W, et al. Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clin Cancer Res. 2019;25(4):1389\u2013403.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5161_CR114","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-018-0901-2","volume":"17","author":"CM Schaal","year":"2018","unstructured":"Schaal CM, Bora-Singhal N, Kumar DM, Chellappan SP. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer. 2018;17(1):149.","journal-title":"Mol Cancer"},{"issue":"3","key":"5161_CR115","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41419-020-2361-z","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Chen S, Zhuo L, Zhu Y, Zheng H. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p\/SOX2 axis in colorectal cancer. Cell Death Dis. 2020;11(3):173.","journal-title":"Cell Death Dis"},{"issue":"2","key":"5161_CR116","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","volume":"39","author":"T Schaefer","year":"2020","unstructured":"Schaefer T, Lengerke C. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond. Oncogene. 2020;39(2):278\u201392.","journal-title":"Oncogene"},{"issue":"7508","key":"5161_CR117","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","volume":"511","author":"S Boumahdi","year":"2014","unstructured":"Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature. 2014;511(7508):246\u201350.","journal-title":"Nature"},{"issue":"3","key":"5161_CR118","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41418-019-0389-3","volume":"27","author":"H Liu","year":"2020","unstructured":"Liu H, Song Y, Qiu H, Liu Y, Luo K, Yi Y, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27(3):966\u201383.","journal-title":"Cell Death Differ"},{"issue":"1","key":"5161_CR119","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mc.23824","volume":"64","author":"Q Xia","year":"2025","unstructured":"Xia Q, Liu G, Lin W, Zhang J. microRNA-2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2. Mol Carcinog. 2025;64(1):33\u201343.","journal-title":"Mol Carcinog"},{"issue":"6","key":"5161_CR120","first-page":"2715","volume":"53","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Pang W, Yang N, Hao L, Wang L. MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K\/Akt pathway. Int J Oncol. 2018;53(6):2715\u201326.","journal-title":"Int J Oncol"},{"issue":"15","key":"5161_CR121","first-page":"4898","volume":"22","author":"YZ Guo","year":"2018","unstructured":"Guo YZ, Xie XL, Fu J, Xing GL. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt\/\u03b2-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(15):4898\u2013907.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"5161_CR122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/hep.28509","volume":"64","author":"C Liu","year":"2016","unstructured":"Liu C, Liu L, Chen X, Cheng J, Zhang H, Shen J, et al. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma. Hepatology. 2016;64(1):117\u201329.","journal-title":"Hepatology"},{"issue":"1","key":"5161_CR123","doi-asserted-by":"publisher","first-page":"30489","DOI":"10.1038\/srep30489","volume":"6","author":"T Kawai","year":"2016","unstructured":"Kawai T, Yasuchika K, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, et al. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma. Sci Rep. 2016;6(1):30489.","journal-title":"Sci Rep"},{"key":"5161_CR124","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.gene.2019.05.015","volume":"707","author":"B Li","year":"2019","unstructured":"Li B, Liu D, Yang P, Li HY, Wang D. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway. Gene. 2019;707:78\u201385.","journal-title":"Gene"},{"issue":"2","key":"5161_CR125","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0378-1119(99)00261-9","volume":"236","author":"MJ Thomas","year":"1999","unstructured":"Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene. 1999;236(2):197\u2013208.","journal-title":"Gene"},{"issue":"2","key":"5161_CR126","first-page":"F49","volume":"1332","author":"Y Shi","year":"1997","unstructured":"Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta. 1997;1332(2):F49\u201366.","journal-title":"Biochim Biophys Acta"},{"key":"5161_CR127","unstructured":"Iuchi S, Kuldell N. Zinc finger proteins: from atomic contact to cellular function. Springer Science & Business Media; 2007."},{"issue":"8","key":"5161_CR128","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","volume":"25","author":"S Gordon","year":"2006","unstructured":"Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 2006;25(8):1125\u201342.","journal-title":"Oncogene"},{"issue":"51","key":"5161_CR129","doi-asserted-by":"publisher","first-page":"19296","DOI":"10.1073\/pnas.0603564103","volume":"103","author":"Wilkinson","year":"2006","unstructured":"Wilkinson FH, Park K, Atchison ML. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci. 2006;103(51):19296\u2013301.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"5161_CR130","first-page":"517","volume":"43","author":"J Li","year":"2019","unstructured":"Li J, Song J, Guo F. miR-186 reverses cisplatin resistance and inhibits the formation of the glioblastoma-initiating cell phenotype by degrading Yin Yang 1 in glioblastoma. Int J Mol Med. 2019;43(1):517\u201324.","journal-title":"Int J Mol Med"},{"key":"5161_CR131","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12935-020-01390-w","volume":"20","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zheng R, Chen J, Ning D. CircRNA CDR1as\/miR-641\/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int. 2020;20:289.","journal-title":"Cancer Cell Int"},{"key":"5161_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12935-017-0398-6","volume":"17","author":"X Guo","year":"2017","unstructured":"Guo X, Yu L, Zhang Z, Dai G, Gao T, Guo W. miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1. Cancer Cell Int. 2017;17:29.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"5161_CR133","doi-asserted-by":"publisher","first-page":"e30599","DOI":"10.1016\/j.heliyon.2024.e30599","volume":"10","author":"F Tolue Ghasaban","year":"2024","unstructured":"Tolue Ghasaban F, Ghanei M, Mahmoudian RA, Taghehchian N, Abbaszadegan MR, Moghbeli M. MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells. Heliyon. 2024;10(9):e30599.","journal-title":"Heliyon"},{"issue":"6","key":"5161_CR134","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"5161_CR135","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12935-024-03357-7","volume":"24","author":"M Moghbeli","year":"2024","unstructured":"Moghbeli M. PI3K\/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells. Cancer Cell Int. 2024;24(1):165.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"5161_CR136","doi-asserted-by":"publisher","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"TL Yeung","year":"2015","unstructured":"Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol. 2015;309(7):C444\u201356.","journal-title":"Am J Physiol Cell Physiol"},{"key":"5161_CR137","doi-asserted-by":"publisher","first-page":"155683","DOI":"10.1016\/j.prp.2024.155683","volume":"263","author":"F Tolue Ghasaban","year":"2024","unstructured":"Tolue Ghasaban F, Moghbeli M. Long non-coding RNAs as the pivotal regulators of epithelial mesenchymal transition through WNT\/beta-catenin signaling pathway in tumor cells. Pathol Res Pract. 2024;263:155683.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"5161_CR138","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/bcr2938","volume":"14","author":"B Dave","year":"2012","unstructured":"Dave B, Mittal V, Tan NM, Chang JC. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res. 2012;14(1):202.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"5161_CR139","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"45","key":"5161_CR140","doi-asserted-by":"publisher","first-page":"19035","DOI":"10.1073\/pnas.0910009106","volume":"106","author":"M Liu","year":"2009","unstructured":"Liu M, Casimiro MC, Wang C, Shirley LA, Jiao X, Katiyar S, et al. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A. 2009;106(45):19035\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5161_CR141","doi-asserted-by":"publisher","first-page":"111817","DOI":"10.1016\/j.yexcr.2020.111817","volume":"391","author":"J Yang","year":"2020","unstructured":"Yang J, Wu S-P, Wang W-J, Jin Z-R, Miao X-B, Wu Y, et al. A novel miR-200c\/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer. Exp Cell Res. 2020;391(2):111817.","journal-title":"Exp Cell Res"},{"key":"5161_CR142","doi-asserted-by":"publisher","first-page":"707424","DOI":"10.3389\/fcell.2021.707424","volume":"9","author":"YJ Dong","year":"2021","unstructured":"Dong YJ, Feng W, Li Y. HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells. Front Cell Dev Biol. 2021;9:707424.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"5161_CR143","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2217\/17460751.1.4.437","volume":"1","author":"DN Haylock","year":"2006","unstructured":"Haylock DN, Nilsson SK. The role of hyaluronic acid in hemopoietic stem cell biology. Regen Med. 2006;1(4):437\u201345.","journal-title":"Regen Med"},{"issue":"1","key":"5161_CR144","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2741\/3687","volume":"16","author":"L Astachov","year":"2011","unstructured":"Astachov L, Vago R, Aviv M, Nevo Z. Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone. Front Biosci. 2011;16(1):261\u201376.","journal-title":"Front Biosci"},{"issue":"3","key":"5161_CR145","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1021\/cr050247k","volume":"106","author":"R Stern","year":"2006","unstructured":"Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818\u201339.","journal-title":"Chem Rev"},{"issue":"2","key":"5161_CR146","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1242\/jcs.103.2.293","volume":"103","author":"C Underhill","year":"1992","unstructured":"Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992;103(2):293\u20138.","journal-title":"J Cell Sci"},{"issue":"2","key":"5161_CR147","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/onc.2011.222","volume":"31","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan\/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 2012;31(2):149\u201360.","journal-title":"Oncogene"},{"issue":"39","key":"5161_CR148","doi-asserted-by":"publisher","first-page":"32800","DOI":"10.1074\/jbc.M111.308528","volume":"287","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon LY, Wong G, Earle C, Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012;287(39):32800\u201324.","journal-title":"J Biol Chem"},{"issue":"1","key":"5161_CR149","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","volume":"75","author":"A Shilatifard","year":"2006","unstructured":"Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem. 2006;75(1):243\u201369.","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"5161_CR150","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","volume":"12","author":"Q Feng","year":"2002","unstructured":"Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K, et al. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol. 2002;12(12):1052\u20138.","journal-title":"Curr Biol"},{"issue":"10","key":"5161_CR151","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1091\/mbc.11.10.3601","volume":"11","author":"PA San-Segundo","year":"2000","unstructured":"San-Segundo PA, Roeder GS. Role for the silencing protein Dot1 in meiotic checkpoint control. Mol Biol Cell. 2000;11(10):3601\u201315.","journal-title":"Mol Biol Cell"},{"issue":"20","key":"5161_CR152","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1074\/jbc.M115.700021","volume":"291","author":"LY Bourguignon","year":"2016","unstructured":"Bourguignon LY, Wong G, Shiina M. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. J Biol Chem. 2016;291(20):10571\u201385.","journal-title":"J Biol Chem"},{"issue":"9","key":"5161_CR153","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10495-007-0087-3","volume":"12","author":"AM Hunter","year":"2007","unstructured":"Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis. 2007;12(9):1543\u201368.","journal-title":"Apoptosis"},{"issue":"8","key":"5161_CR154","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrc2889","volume":"10","author":"M Gyrd-Hansen","year":"2010","unstructured":"Gyrd-Hansen M, Meier P. IAPs: from caspase inhibitors to modulators of NF-\u03baB, inflammation and cancer. Nat Rev Cancer. 2010;10(8):561\u201374.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"5161_CR155","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"M Prince","year":"2007","unstructured":"Prince M, Sivanandan R, Kaczorowski A, Wolf G, Kaplan M, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci. 2007;104(3):973\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"5161_CR156","doi-asserted-by":"publisher","first-page":"e3360","DOI":"10.1371\/journal.pone.0003360","volume":"3","author":"B Mack","year":"2008","unstructured":"Mack B, Gires O. CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE. 2008;3(10):e3360.","journal-title":"PLoS ONE"},{"key":"5161_CR157","doi-asserted-by":"crossref","unstructured":"Bourguignon LY, editor. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Seminars in cancer biology; 2008: Elsevier.","DOI":"10.1016\/j.semcancer.2008.03.007"},{"issue":"7","key":"5161_CR158","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1074\/jbc.R100038200","volume":"277","author":"EA Turley","year":"2002","unstructured":"Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277(7):4589\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"5161_CR159","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ng.268","volume":"41","author":"J Wang","year":"2009","unstructured":"Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet. 2009;41(1):125\u20139.","journal-title":"Nat Genet"},{"issue":"3","key":"5161_CR160","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/nar\/gkq850","volume":"39","author":"S-L Lin","year":"2011","unstructured":"Lin S-L, Chang DC, Lin C-H, Ying S-Y, Leu D, Wu DT. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 2011;39(3):1054\u201365.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5161_CR161","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.devcel.2011.01.006","volume":"20","author":"B Ohkawara","year":"2011","unstructured":"Ohkawara B, Glinka A, Niehrs C. Rspo3 binds syndecan 4 and induces Wnt\/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis. Dev Cell. 2011;20(3):303\u201314.","journal-title":"Dev Cell"},{"issue":"1","key":"5161_CR162","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-021-01993-x","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu Y, Wang T, Xia L, Zhang M. LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p\/SDC4 axis. Cancer Cell Int. 2021;21(1):284.","journal-title":"Cancer Cell Int"},{"key":"5161_CR163","doi-asserted-by":"publisher","first-page":"154672","DOI":"10.1016\/j.prp.2023.154672","volume":"248","author":"N Taghehchian","year":"2023","unstructured":"Taghehchian N, Samsami Y, Maharati A, Zangouei AS, Boroumand-Noughabi S, Moghbeli M. Molecular biology of microRNA-342 during tumor progression and invasion. Pathol Res Pract. 2023;248:154672.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"5161_CR164","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12935-023-02865-2","volume":"23","author":"AA Hamidi","year":"2023","unstructured":"Hamidi AA, Taghehchian N, Zangouei AS, Akhlaghipour I, Maharati A, Basirat Z, et al. Molecular mechanisms of microRNA-216a during tumor progression. Cancer Cell Int. 2023;23(1):19.","journal-title":"Cancer Cell Int"},{"key":"5161_CR165","doi-asserted-by":"crossref","unstructured":"Wilson JE. Hexokinases. Reviews of Physiology, Biochemistry and Pharmacology, Volume 126. 2006:65\u2013198.","DOI":"10.1007\/BFb0049776"},{"key":"5161_CR166","doi-asserted-by":"publisher","first-page":"153303381987130","DOI":"10.1177\/1533033819871306","volume":"18","author":"C Liu","year":"2019","unstructured":"Liu C, Wang X, Zhang Y. The roles of HK2 on tumorigenesis of cervical cancer. Technol Cancer Res Treat. 2019;18:1533033819871306.","journal-title":"Technol Cancer Res Treat"},{"key":"5161_CR167","doi-asserted-by":"publisher","first-page":"581208","DOI":"10.3389\/fonc.2020.581208","volume":"10","author":"N Cui","year":"2020","unstructured":"Cui N, Li L, Feng Q, Ma H-m, Lei D, Zheng P-S. Hexokinase 2 promotes cell growth and tumor formation through the Raf\/MEK\/ERK signaling pathway in cervical cancer. Front Oncol. 2020;10:581208.","journal-title":"Front Oncol"},{"key":"5161_CR168","doi-asserted-by":"crossref","unstructured":"Yang H, Hou H, Zhao H, Yu T, Hu Y, Hu Y et al. HK2 is a crucial downstream regulator of miR-148a for the maintenance of sphere-forming property and cisplatin resistance in cervical cancer cells. Front Oncol. 2021;11:794015.","DOI":"10.3389\/fonc.2021.794015"},{"issue":"5","key":"5161_CR169","first-page":"778","volume":"8","author":"J Long","year":"2018","unstructured":"Long J, Zhang C-J, Zhu N, Du K, Yin Y-F, Tan X, et al. Lipid metabolism and carcinogenesis, cancer development. Am J cancer Res. 2018;8(5):778.","journal-title":"Am J cancer Res"},{"issue":"1","key":"5161_CR170","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/ijms16010924","volume":"16","author":"C Huang","year":"2015","unstructured":"Huang C, Freter C. Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci. 2015;16(1):924\u201349.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5161_CR171","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/1568026618666180523104541","volume":"18","author":"X Cheng","year":"2018","unstructured":"Cheng X, Li J, Guo D. SCAP\/SREBPs are central players in lipid metabolism and novel metabolic targets in cancer therapy. Curr Top Med Chem. 2018;18(6):484\u201393.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"5161_CR172","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2002.tb04261.x","volume":"967","author":"HJ KIM","year":"2002","unstructured":"KIM HJ, Miyazaki M, Man WC, Ntambi JM. Sterol regulatory element-binding proteins (SREBPs) as regulators of lipid metabolism: polyunsaturated fatty acids oppose cholesterol\u2010mediated induction of SREBP\u20101 maturation. Ann N Y Acad Sci. 2002;967(1):34\u201342.","journal-title":"Ann N Y Acad Sci"},{"issue":"13","key":"5161_CR173","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.3390\/ijms23137283","volume":"23","author":"T-Y Tiong","year":"2022","unstructured":"Tiong T-Y, Weng P-W, Wang C-H, Setiawan SA, Yadav VK, Pikatan NW, et al. Targeting the SREBP-1\/Hsa-Mir-497\/SCAP\/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells. Int J Mol Sci. 2022;23(13):7283.","journal-title":"Int J Mol Sci"},{"issue":"32","key":"5161_CR174","doi-asserted-by":"publisher","first-page":"20425","DOI":"10.1074\/jbc.273.32.20425","volume":"273","author":"KM Shetty","year":"1998","unstructured":"Shetty KM, Kurada P, O\u2019Tousa JE. Rab6 Regulation of Rhodopsin Transport inDrosophila. J Biol Chem. 1998;273(32):20425\u201330.","journal-title":"J Biol Chem"},{"key":"5161_CR175","doi-asserted-by":"crossref","unstructured":"Hill E, Clarke M, Barr FA. The Rab6-binding kinesin, Rab6\u2010KIFL, is required for cytokinesis. EMBO J. 2000.","DOI":"10.1093\/emboj\/19.21.5711"},{"issue":"3","key":"5161_CR176","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/mc.22765","volume":"57","author":"L Yang","year":"2018","unstructured":"Yang L, Lin Z, Wang Y, Gao S, Li Q, Li C, et al. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6. Mol Carcinog. 2018;57(3):419\u201328.","journal-title":"Mol Carcinog"},{"issue":"9","key":"5161_CR177","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41419-021-04086-9","volume":"12","author":"A Xie","year":"2021","unstructured":"Xie A, Xu X, Kuang P, Zhang L, Yu F. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR. Cell Death Dis. 2021;12(9):804.","journal-title":"Cell Death Dis"},{"issue":"10","key":"5161_CR178","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/jgh.14649","volume":"34","author":"C Peng","year":"2019","unstructured":"Peng C, Huang K, Liu G, Li Y, Yu C. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3. J Gastroenterol Hepatol. 2019;34(10):1711\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"16","key":"5161_CR179","doi-asserted-by":"publisher","first-page":"8930","DOI":"10.1111\/jcmm.15524","volume":"24","author":"H Lin","year":"2020","unstructured":"Lin H, Zhang L, Zhang C, Liu P. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer. J Cell Mol Med. 2020;24(16):8930\u201341.","journal-title":"J Cell Mol Med"},{"issue":"19","key":"5161_CR180","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1242\/jcs.190017","volume":"129","author":"MA Mandell","year":"2016","unstructured":"Mandell MA, Jain A, Kumar S, Castleman MJ, Anwar T, Eskelinen EL, et al. TRIM17 contributes to autophagy of midbodies while actively sparing other targets from degradation. J Cell Sci. 2016;129(19):3562\u201373.","journal-title":"J Cell Sci"},{"issue":"2","key":"5161_CR181","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbrc.2009.04.010","volume":"383","author":"T Urano","year":"2009","unstructured":"Urano T, Usui T, Takeda S, Ikeda K, Okada A, Ishida Y, et al. TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligase. Biochem Biophys Res Commun. 2009;383(2):263\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"5161_CR182","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/tox.23625","volume":"37","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhao W, Yang R. MiR-1246 is responsible for lung cancer cells-derived exosomes-mediated promoting effects on lung cancer stemness via targeting TRIM17. Environ Toxicol. 2022;37(11):2651\u20139.","journal-title":"Environ Toxicol"},{"issue":"9","key":"5161_CR183","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, Van Galen P, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17(9):1086\u201393.","journal-title":"Nat Med"},{"issue":"6771","key":"5161_CR184","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35001622","volume":"403","author":"S-I Imai","year":"2000","unstructured":"Imai S-I, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795\u2013800.","journal-title":"Nature"},{"issue":"9","key":"5161_CR185","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/mc.22656","volume":"56","author":"L Zhang","year":"2017","unstructured":"Zhang L, Guo X, Zhang D, Fan Y, Qin L, Dong S, et al. Upregulated miR-132 in Lgr5\u2009+\u2009gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1\/CREB\/ABCG2 signaling pathway. Mol Carcinog. 2017;56(9):2022\u201334.","journal-title":"Mol Carcinog"},{"issue":"7","key":"5161_CR186","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/carcin\/bgac093","volume":"45","author":"D Yang","year":"2024","unstructured":"Yang D, Zhang P, Yang Z, Hou G, Yang Z. miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Carcinogenesis. 2024;45(7):463\u201374.","journal-title":"Carcinogenesis"},{"key":"5161_CR187","doi-asserted-by":"publisher","first-page":"120884","DOI":"10.1016\/j.lfs.2022.120884","volume":"307","author":"A Abbasi","year":"2022","unstructured":"Abbasi A, Hosseinpourfeizi M, Safaralizadeh R. All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin. Life Sci. 2022;307:120884.","journal-title":"Life Sci"},{"issue":"14","key":"5161_CR188","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.2174\/0109298673285341231226111553","volume":"32","author":"A Abbasi","year":"2025","unstructured":"Abbasi A, Hosseinpourfeizi M, Safaralizadeh R. Autophagy Inhibition and Sensitization to Cisplatin in Esophageal Cancer Stem-like Cells via All-trans Retinoic Acid-induced miR-30a. Curr Med Chem. 2025;32(14):2854\u201385.","journal-title":"Curr Med Chem"},{"key":"5161_CR189","doi-asserted-by":"publisher","first-page":"152923","DOI":"10.1016\/j.bbrc.2025.152923","volume":"792","author":"SA Kuran","year":"2025","unstructured":"Kuran SA, Adiyil R, Ziksahna K, Ozkan M, Ihlamur M. Nanotechnology-enabled miRNA delivery systems next-generation molecular strategies in cancer therapy. Biochem Biophys Res Commun. 2025;792:152923.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5161_CR190","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-024-02060-5","volume":"23","author":"P Dogra","year":"2024","unstructured":"Dogra P, Shinglot V, Ruiz-Ramirez J, Cave J, Butner JD, Schiavone C, et al. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Mol Cancer. 2024;23(1):156.","journal-title":"Mol Cancer"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05161-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:02:53Z","timestamp":1790643773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5161"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05161-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"343"}}